Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000187501 | SCV000241095 | likely pathogenic | not provided | 2016-11-04 | criteria provided, single submitter | clinical testing | p.Val287Ile (GTA>ATA): c.859 G>A in exon 10 of the GABRA1 gene (NM_000806.5). The Val287Ile missense change in the GABRA1 gene has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is a conservative substitution of one uncharged, non-polar amino acid for another at a position that is conserved across species. In silico analysis is inconsistent with regard to the effect this variant may have on the protein structure/function. Therefore, based on the currently available information, it is unclear whether Val287Ile is a disease-causing mutation or a rare benign variant. The variant is found in CHILD-EPI panel(s). |
Labcorp Genetics |
RCV001216490 | SCV001388290 | uncertain significance | Idiopathic generalized epilepsy; Epilepsy, idiopathic generalized, susceptibility to, 13; Epilepsy, childhood absence 4 | 2021-08-20 | criteria provided, single submitter | clinical testing |